JJ
NBTX

Johnson & Johnson’s Nanobiotix NBTX Stock Holding History

Johnson & Johnson’s Portfolio NBTX Stock Details NBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212M Hold
5,623,816
– – 26.55% 2
2026
Q1 		$174M Hold
5,623,816
– – 26.61% 2
2025
Q4 		$130M Hold
5,623,816
– – 23.43% 2
2025
Q3 		$106M Hold
5,623,816
– – 21.08% 2
2025
Q2 		$25.5M Hold
5,623,816
– – 7.62% 5
2025
Q1 		$20.1M Hold
5,623,816
– – 5.89% 7
2024
Q4 		$16.1M Hold
5,623,816
– – 4.18% 10
2024
Q3 		$32.3M Hold
5,623,816
– – 7.57% 6
2024
Q2 		$28.1M Hold
5,623,816
– – 7.02% 6
2024
Q1 		$36.6M Hold
5,623,816
– – 0.83% 8
2023
Q4 		$40.9M Buy
5,623,816
+4,664,179
+486% +$29.6M 0.93% 6
2023
Q3 		$8.4M Buy
+959,637
New +$7.96M 3.09% 9

Other funds holding NBTX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Johnson & Johnson's NBTX Position: Q2 2026 in Review

Johnson & Johnson held its Nanobiotix (NBTX) position steady in Q2 2026 at 5,623,816 shares worth $212M. The position accounts for 26.55% of the portfolio, ranked #2.

Johnson & Johnson first reported a position in NBTX in Q3 2023 and has held it in 12 quarters since. 11 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

  • Johnson & Johnson held 5,623,816 shares of Nanobiotix worth $212M as of Q2 2026.
  • Johnson & Johnson left its Nanobiotix share count unchanged in Q2 2026.
  • Nanobiotix made up 26.55% of Johnson & Johnson's portfolio in Q2 2026, its #2 holding.
  • Johnson & Johnson first reported a position in Nanobiotix in Q3 2023 and has held it in 12 quarters since.
  • 11 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Johnson & Johnson's 13F filing for Q2 2026, filed 6 Aug 2026.